Search Results

Return to List
Results 41–60 of 95
Title Date
41.

Disclosure and Discussion of Adverse Events

Number 520

(Replaces No. 380, October 2007, Reaffirmed 2014)

ABSTRACT Disclosure and discussion of adverse events in health care with the patient are morally and ethically necessary to achieve the optimal goal of respecting patient autonomy Improving the disclosure process through education policies programmatic training and accessible resources will enhanc...

March 2012

PDF Format
42.

Intimate Partner Violence

Number 518

ABSTRACT Intimate partner violence IPV is a significant yet preventable public health problem that affects millions of women regardless of age economic status race religion ethnicity sexual orientation or educational background Individuals who are subjected to IPV may have lifelong consequences in...

February 2012

PDF Format
43.

Health Care for Pregnant and Postpartum Incarcerated Women and Adolescent Females

Number 511

(Reaffirmed 2013)

ABSTRACT Clinicians who provide care for incarcerated women should be aware of the special health care needs of pregnant incarcerated women and the specific issues related to the use of restraints during pregnancy and the postpartum period The use of restraints on pregnant incarcerated women and a...

November 2011

PDF Format
44.

Understanding and Using the US Medical Eligibility Criteria for Contraceptive Use, 2010

Number 505

(Reaffirmed 2014)

ABSTRACT The 2010 US Medical Eligibility Criteria for Contraceptive Use US MEC issued by the Centers for Disease Control and Prevention gives comprehensive evidencebased guidance to clinicians providing family planning services to women especially women with medical conditions The American College...

September 2011

PDF Format
45.

Maternal-Fetal Intervention and Fetal Care Centers

Number 501

(Reaffirmed 2014)

ABSTRACT The past two decades have yielded profound advances in the fields of prenatal diagnosis and fetal intervention Although fetal interventions are driven by a beneficencebased motivation to improve fetal and neonatal outcomes advancement in fetal therapies raises ethical issues surrounding m...

August 2011

PDF Format
46.

Adult Manifestations of Childhood Sexual Abuse

Number 498

(Reaffirmed 2013)

ABSTRACT Longterm effects of childhood sexual abuse are varied complex and often devastating Many obstetriciangynecologists knowingly or unknowingly provide care to abuse survivors and should screen all women for a history of such abuse Depression anxiety and anger are the most commonly reported e...

August 2011

PDF Format
47.

At-Risk Drinking and Alcohol Dependence: Obstetric and Gynecologic Implications

Number 496

(Reaffirmed 2013)

ABSTRACT Compared with men atrisk alcohol use by women has a disproportionate effect on their health and lives including reproductive function and pregnancy outcomes Obstetriciangynecologists have a key role in screening and providing brief intervention patient education and treatment referral for...

August 2011

PDF Format
48.

Vitamin D: Screening and Supplementation During Pregnancy

Number 495

ABSTRACT During pregnancy severe maternal vitamin D deficiency has been associated with biochemical evidence of disordered skeletal homeostasis congenital rickets and fractures in the newborn At this time there is insufficient evidence to support a recommendation for screening all pregnant women f...

July 2011

PDF Format
49.

Sulfonamides, Nitrofurantoin, and Risk of Birth Defects

Number 494

(Reaffirmed 2013)

Abstract The evidence regarding an association between the nitrofuran and sulfonamide classes of antibiotics and birth defects is mixed As with all patients antibiotics should be prescribed for pregnant women only for appropriate indications and for the shortest effective duration During the secon...

June 2011

PDF Format
50.

Update on Carrier Screening for Cystic Fibrosis

Number 486

(Reaffirmed 2014, Replaces No. 325, December 2005)

ABSTRACT In 2001 the American College of Obstetricians and Gynecologists and the American College of Medical Genetics introduced guidelines for prenatal and preconception carrier screening for cystic fibrosis The American College of Obstetricians and Gynecologists Committee on Genetics has updated...

April 2011

PDF Format
51.

Prevention of Early-Onset Group B Streptococcal Disease in Newborns

Number 485

(Reaffirmed 2013, Replaces No. 279, December 2002)

ABSTRACT In 2010 the Centers for Disease Control and Prevention revised its guidelines for the prevention of perinatal group B streptococcal disease Although universal screening at 3537 weeks of gestation and intrapartum antibiotic prophylaxis continue to be the basis of the prevention strategy th...

April 2011

PDF Format
52.

Methamphetamine Abuse in Women of Reproductive Age

Number 479

(Reaffirmed 2013)

ABSTRACT Methamphetamine abuse has continued to increase in the United States since the late 1980s with its use spreading from the West Coast to areas across the country Methamphetamine use in pregnancy endangers the health of the woman and increases the risk of low birth weight and small for gest...

March 2011

PDF Format
53.

Family History as a Risk Assessment Tool

Number 478

ABSTRACT Family history plays a critical role in assessing the risk of inherited medical conditions and single gene disorders Several methods have been established to obtain family medical histories including the family history questionnaire or checklist and the pedigree The screening tool selecte...

March 2011

PDF Format
54.

Planned Home Birth

Number 476

(Reaffirmed 2013)

ABSTRACT Although the Committee on Obstetric Practice believes that hospitals and birthing centers are the safest setting for birth it respects the right of a woman to make a medically informed decision about delivery Women inquiring about planned home birth should be informed of its risks and ben...

February 2011

PDF Format
55.

Nonobstetric Surgery During Pregnancy

Number 474

(Reaffirmed 2013, Replaces No. 284, August 2003)

ABSTRACT The American College of Obstetricians and Gynecologists Committee on Obstetric Practice acknowledges that the issue of nonobstetric surgery during pregnancy is an important concern for physicians who care for women It is important for a physician to obtain an obstetric consultation before...

February 2011

PDF Format
56.

Smoking Cessation During Pregnancy

Number 471

(Reaffirmed 2013, Replaces No. 316, October 2005)

ABSTRACT Smoking is the one of the most important modifiable causes of poor pregnancy outcomes in the United States and is associated with maternal fetal and infant morbidity and mortality The physical and psychologic addiction to cigarettes is powerful however the compassionate intervention of th...

November 2010

PDF Format
57.

Carrier Screening for Fragile X Syndrome

Number 469

(Reaffirmed 2014, Replaces No. 338, June 2006)

ABSTRACT Fragile X syndrome is the most common inherited form of mental retardation The syndrome occurs in approximately 1 in 3600 males and 1 in 40006000 females Approximately 1 in 250 females carry the premutation DNAbased molecular analysis is the preferred method of diagnosis for fragile X syn...

October 2010

PDF Format
58.

Moderate Caffeine Consumption During Pregnancy

Number 462

(Reaffirmed 2013)

ABSTRACT Moderate caffeine consumption less than 200 mg per day does not appear to be a major contributing factor in miscarriage or preterm birth The relationship of caffeine to growth restriction remains undetermined A final conclusion cannot be made at this time as to whether there is a correlat...

August 2010

PDF Format
59.

Preparing for Disasters: Perspectives on Women

Number 457

(Reaffirmed 2014)

ABSTRACT Emergency plans that specifically address the needs of women infants and children during disasters are currently underdeveloped in the United States Pregnant women infants and children are adversely affected by disasters resulting in an increased number of infants with intrauterine growth...

June 2010

PDF Format
60.

Magnesium Sulfate Before Anticipated Preterm Birth for Neuroprotection

Number 455

(Reaffirmed 2013)

ABSTRACT Numerous large clinical studies have evaluated the evidence regarding magnesium sulfate neuroprotection and preterm births The Committee on Obstetric Practice and the Society for MaternalFetal Medicine recognize that none of the individual studies found a benefit with regard to their prim...

March 2010

PDF Format

American Congress of Obstetricians and Gynecologists
409 12th Street SW, Washington, DC  20024-2188 | Mailing Address: PO Box 70620, Washington, DC 20024-9998